ResearcherThe University of MelbourneActive in the last 2 years
Vijayaragavan Muralidharan
Matched on ORCID iD 0000-0001-8247-8937; OpenAlex author ID A5001618669, A5003280989. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 5
- International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
- A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic adenocarcinoma. First author DOI 10.1186/s12885-026-16113-z↗
- Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and … First author DOI 10.1007/s12029-025-01237-5↗
- Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer. Co-author DOI 10.3748/wjg.v28.i7.745↗
- Serum carbohydrate antigen 19-9 in pancreatic adenocarcinoma: a mini review for surgeons. Last author DOI 10.1111/ans.14131↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Prasad D. Cooray · 2 shared papers, 2025–2026 · strength 0.58
- Paper Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic D… DOI 10.1007/s12029-025-01237-5↗
- Paper A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic aden… DOI 10.1186/s12885-026-16113-z↗
- Kevin Zhao · 1 shared paper, 2025 · strength 0.30
- Sue S. Thang · 1 shared paper, 2026 · strength 0.28
- Ashleigh R. Poh · 1 shared paper, 2026 · strength 0.28
- Adrian M. Fox · 1 shared paper, 2026 · strength 0.28
- Tai Ermongkonchai · 1 shared paper, 2022 · strength 0.17
- Sweet Ping Ng · 1 shared paper, 2022 · strength 0.17
- Niall Christopher Tebbutt · 1 shared paper, 2022 · strength 0.17
- Christopher Christophi · 1 shared paper, 2017 · strength 0.10
- Su Kah Goh · 1 shared paper, 2017 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.